Changes in mortality rates and causes of death in a population-based cohort of persons living with and without HIV from 1996 to 2012

BMC Infectious Diseases

Volumn 17, Issue 1, 2017, Pages

  Eyawo, Oghenowede ^a,b   Franco Villalobos, Conrado ^a   Hull, Mark W ^a   Nohpal, Adriana ^c   Samji, Hasina ^d   Sereda, Paul ^a   Lima, Viviane D ^a   Shoveller, Jeannie ^a,e   Moore, David ^a   Montaner, Julio S G ^a,e   Hogg, Robert S ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b SIMON FRASER UNIVERSITY   (Canada)

^c DataClever Consulting Inc   (Canada)

^d BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Age standardized mortality rate; Cause of death; HIV infection; Mortality; Mortality rate ratio

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE STANDARDIZED MORTALITY RATE; AGED; ANUS CANCER; ARTICLE; BLADDER CANCER; BREAST CANCER; BRITISH COLUMBIA; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COHORT ANALYSIS; COLON CANCER; CONTROLLED STUDY; DRUG ABUSE; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ICD-10; ICD-9; LIVER CANCER; LIVER DISEASE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASM; MIDDLE AGED; MORTALITY RATE; NEUROLOGIC DISEASE; OVARY CANCER; PANCREAS CANCER; POPULATION RESEARCH; PROSTATE CANCER; RECTUM CANCER; RETROSPECTIVE STUDY; STOMACH CANCER; VITAL STATISTICS; CASE CONTROL STUDY; COMORBIDITY; HIV INFECTIONS; MORTALITY; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRITISH COLUMBIA; CASE-CONTROL STUDIES; CAUSE OF DEATH; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 85014222260     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-017-2254-7     Document Type: Article

References (50)

1. Hogg RS, Heath KV, Yip B, Craib KJ, O'Shaughnessy MV, Schechter MT, Montaner JS. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA. 1998;279(6):450-4.
2. Palella Jr FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338(13):853-60.
3. Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d'Arminio Monforte A, Knysz B, Dietrich M, Phillips AN, Lundgren JD. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003;362(9377):22-9.
4. Bangsberg DR, Ragland K, Monk A, Deeks SG. A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed people. AIDS. 2010;24(18):2835-40.
5. Nachega JB, Parienti JJ, Uthman OA, Gross R, Dowdy DW, Sax PE, Gallant JE, Mugavero MJ, Mills EJ, Giordano TP. Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials. Clin Infect Dis. 2014;58(9):1297-307.
6. Lima VD, Hogg RS, Harrigan PR, Moore D, Yip B, Wood E, Montaner JS. Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy. AIDS. 2007;21(6):685-92.
7. World Health Organization (WHO): HIV/AIDS in Europe - Moving from death sentence to chronic disease management. Accessed at: http://www.euro.who.int/en/what-we-publish/abstracts/hivaids-in-europe.-moving-from-death-sentence-to-chronic-disease-management on August 16, 2016: WHO Regional Office for Europe; 2006.
8. Samji H, Cescon A, Hogg RS, Modur SP, Althoff KN, Buchacz K, Burchell AN, Cohen M, Gebo KA, Gill MJ, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One. 2013;8(12):e81355.
9. Mills EJ, Bakanda C, Birungi J, Chan K, Ford N, Cooper CL, Nachega JB, Dybul M, Hogg RS. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med. 2011;155(4):209-16.
10. Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372(9635):293-9.
11. Mocroft A, Brettle R, Kirk O, Blaxhult A, Parkin JM, Antunes F, Francioli P, D'Arminio Monforte A, Fox Z, Lundgren JD, et al. Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS. 2002;16(12):1663-71.
12. Crum NF, Riffenburgh RH, Wegner S, Agan BK, Tasker SA, Spooner KM, Armstrong AW, Fraser S, Wallace MR, Triservice ACC. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr. 2006;41(2):194-200.
13. Krentz HB, Kliewer G, Gill MJ. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. HIV Med. 2005;6(2):99-106.
14. Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis. 2010;50(10):1387-96.
15. Palella Jr FJ, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, Holmberg SD, Investigators HIVOS. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43(1):27-34.
16. Leone S, Gregis G, Quinzan G, Velenti D, Cologni G, Soavi L, Ravasio V, Ripamonti D, Suter F, Maggiolo F. Causes of death and risk factors among HIV-infected persons in the HAART era: analysis of a large urban cohort. Infection. 2011;39(1):13-20.
17. Hogg RS, Heath KV, Strathdee SA, Montaner JS, O'Shaughnessy MV, Schechter MT. HIV/AIDS mortality in Canada: evidence of gender, regional and local area differentials. AIDS. 1996;10(8):889-94.
18. Lima VD, Lepik KJ, Zhang W, Muldoon KA, Hogg RS, Montaner JS. Regional and temporal changes in HIV-related mortality in British Columbia, 1987-2006. Can J Public Health. 2010;101(5):415-9.
19. Belvedere LM, Miller CL, Hogg RS. Shifting sands: changing regional and gender-specific patterns of HIV/AIDS mortality in Canada, 1987 to 2008. Can J Public Health. 2012;103(3):202-6.
20. Lima VD, Eyawo O, Ma H, Lourenco L, Chau W, Hogg RS, Montaner JS. The impact of scaling-up combination antiretroviral therapy on patterns of mortality among HIV-positive persons in British Columbia, Canada. J Int AIDS Soc. 2015;18:20261.
21. Cheung CC, Ding E, Sereda P, Yip B, Lourenco L, Barrios R, Montaner J, Hogg RS, Lima V, Moore DM. Reductions in all-cause and cause-specific mortality among HIV-infected individuals receiving antiretroviral therapy in British Columbia, Canada: 2001-2012. HIV Med. 2016;17(9):694-701.
22. BC Centre for Excellence in HIV/AIDS. Drug Treatment Program and Laboratory. BC Centre for Excellence in HIV/AIDS; 2014.http://www.cfenet.ubc.ca/drug-treatment-program and http://www.cfenet.ubc.ca/research/laboratory-program
23. Population Data BC: About Population Data BC. Accessed at: http://www.popdata.bc.ca/aboutus on January 17, 2017: Population Data BC; 2017.
24. British Columbia Ministry of Health (2014). Medical Services Plan (MSP) Payment Information File. Population Data BC. Data Extract. MOH. 2014. http://www.popdata.bc.ca/data.
25. British Columbia Ministry of Health (2014). Consolidation File (MSP Registration & Premium Billing). Population Data BC. Data Extract. MOH. 2014. http://www.popdata.bc.ca/data.
26. Canadian Institute for Health Information (2014). Discharge Abstract Database (Hospital Separations). Population Data BC. Data Extract. MOH. 2014. http://www.popdata.bc.ca/data.
27. BC Cancer Agency Registry Data (2014). Population Data BC. Data Extract. BC Cancer Agency; 2014. http://www.popdata.bc.ca/data.
28. British Columbia Ministry of Health (2012). Mental Health. Population Data BC. Data Extract. MOH. 2014. http://www.popdata.bc.ca/data.
29. British Columbia Ministry of Health. PharmaCare. Population Data BC. Data Extract. MOH. 2014. http://www.popdata.bc.ca/data.
30. British Columbia Ministry of Health (2014). PharmaNet. BC Ministry of Health Data Extract. Data Stewardship Committee. 2014. http://www.popdata.bc.ca/data.
31. British Columbia Vital Statistics Agency (2014). Vital Statistics Deaths. Population Data BC. Data Extract. BC Vital Statistics Agency. 2014. http://www.popdata.bc.ca/data.
32. Nosyk B, Colley G, Yip B, Chan K, Heath K, Lima VD, Gilbert M, Hogg RS, Harrigan PR, Montaner JS. Application and validation of case-finding algorithms for identifying individuals with human immunodeficiency virus from administrative data in British Columbia, Canada. PLoS One. 2013;8(1):e54416.
33. Chiang CL: Standard error of the age-adjusted death rate. In: Vital Statistics Special Reports Volume 47, edn. Edited by US Department of Health Education and Welfare; 1961: 271-285.
34. Breslow NE, Day NE. Statistical methods in cancer research. Volume II-The design and analysis of cohort studies. IARC Sci Publ. 1987;82:1-406.
35. Statistics Canada: Table 051-0001 - Estimates of population, by age group and sex for July 1, Canada, provinces and territories, annual. CANSIM database. Accessed at: http://www5.statcan.gc.ca/cansim/a26?lang=eng&id=510001 on January 17, 2017: Statistics Canada; 2015.
36. Martinez E, Milinkovic A, Buira E, de Lazzari E, Leon A, Larrousse M, Lonca M, Laguno M, Blanco JL, Mallolas J, et al. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area. HIV Med. 2007;8(4):251-8.
37. Lohse N, Hansen AB, Pedersen G, Kronborg G, Gerstoft J, Sorensen HT, Vaeth M, Obel N. Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med. 2007;146(2):87-95.
38. Croxford S, Kitching A, Desai S, Kall M, Edelstein M, Delpech V. Survival and causes of death among people diagnosed with HIV infection in England and Wales in the era of effective antiretroviral therapy. HIV Med. 2015;16 Suppl 2:47.
39. Lewden C, Salmon D, Morlat P, Bevilacqua S, Jougla E, Bonnet F, Heripret L, Costagliola D, May T, Chene G, et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol. 2005;34(1):121-30.
40. Smith CJ, Ryom L, Weber R, Morlat P, Pradier C, Reiss P, Kowalska JD, de Wit S, Law M, el Sadr W, et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet. 2014;384(9939):241-8.
41. Aldaz P, Moreno-Iribas C, Egues N, Irisarri F, Floristan Y, Sola-Boneta J, Martinez-Artola V, Sagredo M, Castilla J. Mortality by causes in HIV-infected adults: comparison with the general population. BMC Public Health. 2011;11:300.
42. Weber R, Ruppik M, Rickenbach M, Spoerri A, Furrer H, Battegay M, Cavassini M, Calmy A, Bernasconi E, Schmid P, et al. Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV Med. 2013;14(4):195-207.
43. Arnold DM, Julian JA, Walker IR, Association of Hemophilia Clinic Directors of C. Mortality rates and causes of death among all HIV-positive individuals with hemophilia in Canada over 21years of follow-up. Blood. 2006;108(2):460-4.
44. Klein MB, Rollet-Kurhajec KC, Moodie EE, Yaphe S, Tyndall M, Walmsley S, Gill J, Martel-Laferriere V, Cooper C, Canadian Co-infection Cohort I. Mortality in HIV-hepatitis C co-infected patients in Canada compared to the general Canadian population (2003-2013). AIDS. 2014;28(13):1957-65.
45. van Sighem A, Danner S, Ghani AC, Gras L, Anderson RM, de Wolf F, Study ANOC. Mortality in patients with successful initial response to highly active antiretroviral therapy is still higher than in non-HIV-infected individuals. J Acquir Immune Defic Syndr. 2005;40(2):212-8.
46. BC Centre for Excellence in HIV/AIDS: Treatment as Prevention. Accessed at: http://www.cfenet.ubc.ca/tasp on January 16, 2017: BC Centre for Excellence in HIV/AIDS; 2017.
47. Montaner JS. Treatment as prevention-a double hat-trick. Lancet. 2011;378(9787):208-9.
48. Montaner JS, Hogg RS, Wood E, Kerr T, Tyndall M, Levy AR, Harrigan PR. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet. 2006;368(9534):531-6.
49. Joy R, Druyts EF, Brandson EK, Lima VD, Rustad CA, Zhang W, Wood E, Montaner JS, Hogg RS. Impact of neighborhood-level socioeconomic status on HIV disease progression in a universal health care setting. J Acquir Immune Defic Syndr. 2008;47(4):500-5.
50. Collaboration of Observational HIV Epidemiological Research Europe in EuroCoord (COHERE), Lewden C, Bouteloup V, De Wit S, Sabin C, Mocroft A, Wasmuth JC, van Sighem A, Kirk O, Obel N, et al. All-cause mortality in treated HIV-infected adults with CD4 ≥ 500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. Int J Epidemiol. 2012;41(2):433-45.